Steroid replacement in primary adrenal failure does not appear to affect circulating adipokines

Area of Science:

• Endocrinology
• Metabolic Syndrome
• Adipose Tissue Biology

Background:

• Primary adrenal insufficiency (PAI) is linked to increased cardiometabolic risk and mortality despite steroid replacement.
• Adipokines, such as leptin, adiponectin, and resistin, are key indicators of metabolic dysfunction originating from adipose tissue.

Purpose of the Study:

• To investigate serum adipokine levels (leptin, adiponectin, resistin) in patients with PAI undergoing conventional steroid substitution.
• To compare adipokine profiles between PAI patients and healthy controls and explore correlations with metabolic parameters.

Main Methods:

• Cross-sectional study involving 63 PAI patients and 63 healthy controls.
• Assessed serum adipokines, lipid profiles, glucose, insulin, HOMA-IR, and body composition (DXA).
• Analyzed correlations between adipokines and clinical/biochemical parameters, including hormone levels and medication (DHEA).

Main Results:

• Serum resistin levels were significantly lower in PAI patients compared to controls (p=0.0002).
• Leptin and adiponectin levels did not differ between groups; leptin correlated with insulin resistance and body fat.
• No correlations were found between adipokines and cortisol levels or hydrocortisone dosage; DHEA use was associated with lower leptin and adiponectin.

Conclusions:

• Conventional glucocorticoid replacement in PAI does not appear to induce an adverse adipokine profile.
• Adipokine correlations with metabolic factors in treated PAI patients resemble those in healthy individuals.
• Further research is needed to understand the excess cardiovascular mortality observed in PAI.